| 000 | 01451 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250518071839.0 | ||
| 264 | 0 | _c20210105 | |
| 008 | 202101s 0 0 eng d | ||
| 022 | _a1096-1186 | ||
| 024 | 7 |
_a10.1016/j.phrs.2019.104558 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSvarcbahs, Reinis | |
| 245 | 0 | 0 |
_aProlyl oligopeptidase inhibition activates autophagy via protein phosphatase 2A. _h[electronic resource] |
| 260 |
_bPharmacological research _c01 2020 |
||
| 300 |
_a104558 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAutophagy _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aGene Deletion |
| 650 | 0 | 4 | _aHEK293 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 |
_aProlyl Oligopeptidases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProtein Phosphatase 2 _xmetabolism |
| 700 | 1 | _aJäntti, Maria | |
| 700 | 1 | _aKilpeläinen, Tommi | |
| 700 | 1 | _aJulku, Ulrika H | |
| 700 | 1 | _aUrvas, Lauri | |
| 700 | 1 | _aKivioja, Saara | |
| 700 | 1 | _aNorrbacka, Susanna | |
| 700 | 1 | _aMyöhänen, Timo T | |
| 773 | 0 |
_tPharmacological research _gvol. 151 _gp. 104558 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.phrs.2019.104558 _zAvailable from publisher's website |
| 999 |
_c30344053 _d30344053 |
||